New directions in drug approval

CMAJ. Canadian Medical Association Journal

Volumn 171, Issue 3, 2004, Pages 229-230

  Lexchin, Joel ^a,b  

^a YORK UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DATA BASE; DRUG APPROVAL; DRUG COST; DRUG EFFICACY; DRUG INDUSTRY; DRUG INFORMATION; DRUG MANUFACTURE; DRUG MARKETING; DRUG SAFETY; RESOURCE MANAGEMENT;

EID: 4043052331     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.1040330     Document Type: Article

References (9)

1. Government of Canada. The Canada we want: Speech from the Throne to open the Second Session of the Thirty-Seventh Parliament of Canada. Available: www.sft-ddt.gc.ca/vnav/07_e.htm. (accessed 2004 Jul 6).
2. Department of Finance, Canada. Building the Canada we want. Budget 2003: investing in Canada's health care system [cat no F1-23/2003-4E]. Ottawa: The Department; 2003. Available: www.fin.gc.ca/budget03/booklets/bkheae.htm (accessed 2004 Jul 6).
3. Health Canada. Improving Canada's regulatory process for therapeutic products: building the action plan. Public Policy Forum multi-stakeholder consultation; 2003 Nov 2-3. Available: www.ppforum.ca/ow/ow_e_05_2003/ Presentation%20_Overview_of_Action_Plan.pdf (accessed 2004 Jul 6).
4. Rawson NSB. Timeliness of review and approval of new drugs in Canada from 1999 through 2001: Is progress being made? Clin Ther 2003;25:1230-47.
5. Patented Medicine Prices Review Board. Annual report 2001. Ottawa: The Board; 2002.
6. Rx&D (Canada's Research-Based Pharmaceutical Companies). Improving health through innovation: a new deal for Canadians. Ottawa; 2002. Available: www.canadapharma.org/Media_Centre/Special_Reports/Brief-innovation-sept-02_e. pdf (accessed 2004 July 6).
7. Business Coalition on Cost Recovery. Roy Cullen congratulated on passage of C-212 [news release], 2004 Mar 26. Available: www2.cdn-news.com/scripts/ccn- release.pl?/2004/03/26/0326095n.html?cp=baystreet2 (accessed 2004 Jul 6).
8. Health Canada, KPMG Consulting. Review of the Therapeutic Products Programme cost recovery initiative. Executive summary. Available: www.hc-se.gc.ca/hpfb-dgpsa/tpd-dpt/exec-sum_e.html (accessed 2004 Jul 6).
9. Notes for Roy Cullen. Canadian Consumer Specialty Products Association Annual Federal Government Interface Conference 2004. Ottawa; 2004 Feb 3. Available: www.roycullen.com/reports/notes_C212_2004.htm (accessed 2004 Jul 6).